← Leaderboards
Rasheed Adebayo Gbadegesin
Duke University
$10,821,739
Attributed
$14,540,012
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,540,012 · 11
By mechanism
U01$5,858,766 · 2
R01$5,037,939 · 3
K12$1,577,781 · 1
R21$871,650 · 2
K08$664,634 · 1
R25$411,492 · 1
Top collaborators
- Amber Reeves-Daniel9 shared
- Annette Marie Jackson5 shared
- Laura P Svetkey1 shared
Most similar at Duke University
Same institution · by research overlap
- Joseph Heitman$44,576,851
- William J Steinbach$15,812,111
- John R. Perfect$12,760,645
- Gentzon Hall$793,932
- Andrew Serghios Barbas$3,383,335
Others in their field
Top investigators on “Cohort”
- David R. Weir · University Of Michigan At Ann Arbor$406,814,098
- George R Seage · Abt Associates, Inc.$297,656,361
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$242,146,554
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$227,738,417
- Lawrence Corey · Fred Hutchinson Cancer Center$227,738,417
- James Dennis Neaton · Northwestern University$203,539,316
Research focus
CohortKidney DiseasesGenesEnd Stage Renal FailureGeneticVariantKidneyPathogenesisMolecularPrevalenceGenotypeLeadRenal Glomerular DiseaseAffectResourcesNephrologyBaseProgramsProteinsFocal Segmental GlomerulosclerosisPhenotypeNew Therapeutic TargetInsightFuture
Grant awards (41)
CTSA K12 Program at Duke University$1,577,781
K12 · FY2025 · TR
REGULATORS OF CALCINEURIN PATHWAYS AS DIAGNOSTIC AND THERAPEUTIC TARGETS FOR NEPHROTIC SYNDROME$598,348
R01 · FY2025 · DK · contact PI
13/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center$302,381
U01 · FY2025 · DK
The Paired Undergraduate Mentoring Program (PUMP) in Uronephrology$100,950
R25 · FY2025 · DK · contact PI
REGULATORS OF CALCINEURIN PATHWAYS AS DIAGNOSTIC AND THERAPEUTIC TARGETS FOR NEPHROTIC SYNDROME$658,609
R01 · FY2024 · DK · contact PI
Defining the Landscape of HLA Risk Alleles in Primary Nephrotic Syndrome and Post Kidney Transplant Recurrence$650,335
U01 · FY2024 · AI · contact PI
13/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center$300,000
U01 · FY2024 · DK
The Paired Undergraduate Mentoring Program (PUMP) in Uronephrology$102,030
R25 · FY2024 · DK · contact PI
Defining the Landscape of HLA Risk Alleles in Primary Nephrotic Syndrome and Post Kidney Transplant Recurrence$750,110
U01 · FY2023 · AI · contact PI
REGULATORS OF CALCINEURIN PATHWAYS AS DIAGNOSTIC AND THERAPEUTIC TARGETS FOR NEPHROTIC SYNDROME$713,262
R01 · FY2023 · DK · contact PI
13/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center$180,129
U01 · FY2023 · DK
The Paired Undergraduate Mentoring Program (PUMP) in Uronephrology$103,892
R25 · FY2023 · DK · contact PI
Defining the Landscape of HLA Risk Alleles in Primary Nephrotic Syndrome and Post Kidney Transplant Recurrence$775,109
U01 · FY2022 · AI · contact PI
Wake Forest Collaborative Application for an APOLLO Clinical Center$220,830
U01 · FY2022 · DK
GENETIC BASIS OF CORTICOSTEROID RESPONSE IN CHILDHOOD NEPHROTIC SYNDROME$201,250
R21 · FY2022 · HD · contact PI
The Paired Undergraduate Mentoring Program (PUMP) in Uronephrology$104,620
R25 · FY2022 · DK · contact PI
Defining the Landscape of HLA Risk Alleles in Primary Nephrotic Syndrome and Post Kidney Transplant Recurrence$783,060
U01 · FY2021 · AI · contact PI
GENETIC BASIS OF CORTICOSTEROID RESPONSE IN CHILDHOOD NEPHROTIC SYNDROME$241,500
R21 · FY2021 · HD · contact PI
Defining the Landscape of HLA Risk Alleles in Primary Nephrotic Syndrome and Post Kidney Transplant Recurrence$779,840
U01 · FY2020 · AI · contact PI
Wake Forest Collaborative Application for an APOLLO Clinical Center$133,332
U01 · FY2020 · DK
Wake Forest Collaborative Application for an APOLLO Clinical Center$346,142
U01 · FY2019 · DK
Functional and Phenotypic Characterization of a New FSGS Gene$356,954
R01 · FY2018 · DK · contact PI
Wake Forest Collaborative Application for an APOLLO Clinical Center$269,852
U01 · FY2018 · DK
Wake Forest Collaborative Application for an APOLLO Clinical Center$84,825
U01 · FY2018 · DK
Functional and Phenotypic Characterization of a New FSGS Gene$356,954
R01 · FY2017 · DK · contact PI
Wake Forest Collaborative Application for an APOLLO Clinical Center$282,821
U01 · FY2017 · DK
Gene Discovery in Autosomal Dominant Focal Segmental Glomerulosclerosis$429,265
R01 · FY2016 · DK · contact PI
Functional and Phenotypic Characterization of a New FSGS Gene$356,954
R01 · FY2016 · DK · contact PI
Gene Discovery in Autosomal Dominant Focal Segmental Glomerulosclerosis$429,265
R01 · FY2015 · DK · contact PI
Functional and Phenotypic Characterization of a New FSGS Gene$356,582
R01 · FY2015 · DK · contact PI
Gene Discovery in Autosomal Dominant Focal Segmental Glomerulosclerosis$429,265
R01 · FY2014 · DK · contact PI
Functional and Phenotypic Characterization of a New FSGS Gene$352,481
R01 · FY2014 · DK · contact PI
IDENTIFICATION OF VUR GENES BY COMBINED LINKAGE ANALYSIS AND EXOME SEQUENCING$235,500
R21 · FY2014 · DK · contact PI
IDENTIFICATION OF VUR GENES BY COMBINED LINKAGE ANALYSIS AND EXOME SEQUENCING$193,400
R21 · FY2013 · DK · contact PI
Functional and Phenotypic Characterization of a New FSGS Gene$117,750
R56 · FY2013 · DK · contact PI
A New Locus for Hereditary FSGS on Chromosome 2p$84,471
K08 · FY2013 · DK · contact PI
A New Locus for Hereditary FSGS on Chromosome 2p$939
K08 · FY2013 · DK · contact PI
A New Locus for Hereditary FSGS on Chromosome 2p$144,806
K08 · FY2012 · DK · contact PI
A New Locus for Hereditary FSGS on Chromosome 2p$144,806
K08 · FY2011 · DK · contact PI
A New Locus for Hereditary FSGS on Chromosome 2p$144,806
K08 · FY2010 · DK · contact PI
A New Locus for Hereditary FSGS on Chromosome 2p$144,806
K08 · FY2009 · DK · contact PI